adrian ishkanian
adrian ishkanian
Walker Family Cancer Center Niagara Health
Verified email at
Cited by
Cited by
A tiling resolution DNA microarray with complete coverage of the human genome
AS Ishkanian, CA Malloff, SK Watson, RJ DeLeeuw, B Chi, BP Coe, ...
Nature genetics 36 (3), 299-303, 2004
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer
M Milosevic, P Warde, C Ménard, P Chung, A Toi, A Ishkanian, M McLean, ...
Clinical cancer research 18 (7), 2108-2114, 2012
Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
G Zafarana, AS Ishkanian, CA Malloff, JA Locke, J Sykes, J Thoms, ...
Cancer 118 (16), 4053-4062, 2012
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
High‐resolution array CGH identifies novel regions of genomic alteration in intermediate‐risk prostate cancer
AS Ishkanian, CA Mallof, J Ho, A Meng, M Albert, A Syed, ...
The Prostate 69 (10), 1091-1100, 2009
Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer
C Garnis, BP Coe, A Ishkanian, L Zhang, MP Rosin, WL Lam
Genes, Chromosomes and Cancer 39 (1), 93-98, 2004
NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy
JA Locke, G Zafarana, AS Ishkanian, M Milosevic, J Thoms, CL Have, ...
Clinical cancer research 18 (1), 308-316, 2012
Developing a predictive model for clinical outcomes of advanced non-small cell lung cancer patients treated with nivolumab
W Park, D Kwon, D Saravia, A Desai, F Vargas, M El Dinali, J Warsch, ...
Clinical lung cancer 19 (3), 280-288. e4, 2018
An efficient method for the assessment of DNA quality of archival microdissected specimens
A Siwoski, A Ishkanian, C Garnis, L Zhang, M Rosin, WL Lam
Modern pathology 15 (8), 889-892, 2002
Upfront observation versus radiation for adult pilocytic astrocytoma
A Ishkanian, NJ Laperriere, W Xu, BA Millar, D Payne, W Mason, ...
Cancer 117 (17), 4070-4079, 2011
Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma
CM McKee, D Xu, Y Cao, S Kabraji, D Allen, V Kersemans, J Beech, ...
The Journal of clinical investigation 122 (11), 4025-4036, 2012
TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair
A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ...
Clinical Cancer Research 19 (18), 5202-5209, 2013
Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer
AS Ishkanian, G Zafarana, J Thoms, RG Bristow
Acta oncologica 49 (7), 888-894, 2010
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
A Berlin, E Lalonde, J Sykes, G Zafarana, KC Chu, VR Ramnarine, ...
Oncotarget 5 (22), 11081, 2014
Radiation-induced enhancement of antitumor T-cell immunity by VEGF-targeted 4-1BB costimulation
B Schrand, B Verma, A Levay, S Patel, I Castro, AP Benaduce, ...
Cancer research 77 (6), 1310-1321, 2017
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays
SK Watson, RJ DeLeeuw, AS Ishkanian, CA Malloff, WL Lam
BMC genomics 5, 1-8, 2004
4-1BB aptamer-based immunomodulation enhances the therapeutic index of radiation therapy in murine tumor models
AP Benaduce, R Brenneman, B Schrand, A Pollack, E Gilboa, A Ishkanian
International Journal of Radiation Oncology* Biology* Physics 96 (2), 458-461, 2016
Posterior sternoclavicular joint dislocation: case report and discussion
N Kuzak, A Ishkanian, RB Abu-Laban
Canadian Journal of Emergency Medicine 8 (5), 355-357, 2006
P1. 07-025 correlating ISEND and tumor mutation burden (TMB) with clinical outcomes of advanced non-small cell lung cancer (ANSCLC) patients on nivolumab
W Park, G Lopes, D Kwon, V Florou, YK Chae, J Warsch, A Ishkanian, ...
Journal of Thoracic Oncology 12 (11), S2005-S2006, 2017
The system can't perform the operation now. Try again later.
Articles 1–20